Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210138) titled 'Clinical Investigation of PerioGard (Test) Regimen' on Sept. 29.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Colgate Palmolive

Condition: Gingivitis

Intervention: Drug: PeriGuard regimen

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 18, 2025

Target Sample Size: 80

Countries of Recruitment: Thailand

To know more, visit https://clinicaltrials.gov/study/NCT07210138

Published by HT ...